You are here

  • Home
  • Archive
  • Volume 2012, Issue
  • Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data

Article info

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data

Authors

  • Eleanor F Sprake Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology, University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Vicky A Grant Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology, University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  • Bernard M Corfe Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology, University of Sheffield, Sheffield, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bernard Michael Corfe, b.m.corfe{at}sheffield.ac.uk
View Full Text

Citation

Sprake EF, Grant VA, Corfe BM
Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data
Case Reports 2012;2012:bcr-2012-007223.

Publication history

  • First published December 13, 2012.
Online issue publication 
August 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2012 BMJ Publishing Group Ltd